Organovo Holdings Falling on Insider Sales

Organovo Holdings ONVO shares were dipping this morning after the company filed an SEC from 8-K following the close Thursday.

The form detailed out a series of 10b5-1 plans, which allow an executive to sell shares of the company gradually in order to diversify their personal holdings.

New plans listed in the form 8-K was Keith Murphy, the company's President and CEO, and Michael Renard, who is the company's Executive Vice President of commercial operations.

Insider sales from company executives at the level of Murphy can often put fear into shareholders, who sometimes interpret the move as a lack of confidence in the share price.

Other recently filed 10b5-1 plans came from the company CFO, Barry Michaels, the company CTO and EVP of research ,Sharon Presnell, and the Chief Strategy officer, Eric David.

Organovo has been the subject of a recent Citron research report, which accuses the company of "boiler room action". The report can be read here.

The filings for insider sales caused shares to dip 2.23 percent in the pre-market to $9.64.